NY-ESO-1 TCR Engineered Adoptive Cell Transfer Therapy with PD-1 Blockade - Stand Up To Cancer

Blog

Posted October 11, 2019

NY-ESO-1 TCR Engineered Adoptive Cell Transfer Therapy with PD-1 Blockade

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Please validate the captcha
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.